AR and prostate cancer: Both ligands repressed DHT (1nM)-dependent induction of ARE-regulated reporters in LNCaP prostate cancer cells that express endogenous ARs (Fig 1A) and in PC3 and HEK293T cells transfected with an AR expression vector (Fig 1B and 1C).